Cochrane review of capecitabine for hormone receptor positive versus hormone receptor negative breast cancer

A. Redfern, P. Lau, Andrew White, S. Hoon, M. Bulsara, A. Long

Research output: Contribution to journalAbstract/Meeting Abstract

Original languageEnglish
Number of pages2
JournalCancer Research
Volume77
DOIs
Publication statusPublished - Feb 2017
EventSan Antonio Breast Cancer Symposium - San Antonio
Duration: 6 Dec 201610 Dec 2016

Cite this

@article{09028f30d293407b94f5aac38f56201a,
title = "Cochrane review of capecitabine for hormone receptor positive versus hormone receptor negative breast cancer",
author = "A. Redfern and P. Lau and Andrew White and S. Hoon and M. Bulsara and A. Long",
year = "2017",
month = "2",
doi = "10.1158/1538-7445.SABCS16-P2-12-02",
language = "English",
volume = "77",
journal = "Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research (AACR)",

}

Cochrane review of capecitabine for hormone receptor positive versus hormone receptor negative breast cancer. / Redfern, A.; Lau, P.; White, Andrew; Hoon, S.; Bulsara, M.; Long, A.

In: Cancer Research, Vol. 77, 02.2017.

Research output: Contribution to journalAbstract/Meeting Abstract

TY - JOUR

T1 - Cochrane review of capecitabine for hormone receptor positive versus hormone receptor negative breast cancer

AU - Redfern, A.

AU - Lau, P.

AU - White, Andrew

AU - Hoon, S.

AU - Bulsara, M.

AU - Long, A.

PY - 2017/2

Y1 - 2017/2

U2 - 10.1158/1538-7445.SABCS16-P2-12-02

DO - 10.1158/1538-7445.SABCS16-P2-12-02

M3 - Abstract/Meeting Abstract

VL - 77

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

ER -